| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Relay Therapeutics, Inc. (RLAY) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. RLAY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.45M | $20.43M | - | |
| Dir | 421.2K | $5.94M | - | |
| Pres | 420.0K | $5.92M | - | |
| Other | 371.5K | $5.23M | - | |
| Other | 276.6K | $3.90M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 27, 2024 | Bergstrom Donald A75 | President, R&D | Sell | 648 | $6.26 | $4,056.48 | -0.1% | +12.1% | -47.6% | |
| Jun 27, 2024 | Catinazzo Thomas71 | Chief Financial Officer | Sell | 9,373 | $6.24 | $58,493.42 | -1.4% | +12.1% | -47.6% | |
| Jun 27, 2024 | Adams Brian72 | Chief Legal Officer | Sell | 295 | $6.26 | $1,846.70 | - | +12.1% | -47.6% | |
| Jun 5, 2024 | Rahmer Peter63 | See Remarks | Sell | 80,909 | $6.70 | $542,447.88 | -5.5% | -11.9% | -55.9% | |
| Apr 29, 2024 | Rahmer Peter63 | See Remarks | Sell | 1,345 | $6.38 | $8,581.10 | -0.3% | +24.7% | -53.0% | |
| Apr 29, 2024 | Adams Brian72 | Chief Legal Officer | Sell | 1,623 | $6.38 | $10,354.74 | -0.5% | +24.7% | -53.0% | |
| Apr 29, 2024 | Catinazzo Thomas71 | Chief Financial Officer | Sell | 1,695 | $6.38 | $10,814.10 | -0.5% | +24.7% | -53.0% | |
| Apr 29, 2024 | Bergstrom Donald A75 | President, R&D | Sell | 2,686 | $6.38 | $17,136.68 | -0.5% | +24.7% | -53.0% | |
| Mar 27, 2024 | Catinazzo Thomas71 | Chief Financial Officer | Sell | 348 | $7.70 | $2,679.60 | -0.1% | -17.4% | -63.4% | |
| Mar 27, 2024 | Bergstrom Donald A75 | President, R&D | Sell | 765 | $7.70 | $5,890.50 | -0.1% | -17.4% | -63.4% |